SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001654954-18-013052
Filing Date
2018-11-20
Accepted
2018-11-20 17:05:24
Documents
5
Period of Report
2018-11-19
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT mbvx8k_nov192018.htm 8-K 43378
2 EQUITY PURCHASE AGREEMENT WITH TRITON FUNDS LP ex10-1.htm EX-10.1 313676
3 REGISTRATION RIGHTS AGREEMENT ex10-2.htm EX-10.2 104890
4 SHARE DONATION AGREEMENT ex10-3.htm EX-10.3 11652
5 IMAGE ex10-3000.jpg GRAPHIC 6043
  Complete submission text file 0001654954-18-013052.txt   483363
Mailing Address 11535 SORRENTO VALLEY ROAD SUITE 400 SAN DIEGO CA 92121
Business Address 11535 SORRENTO VALLEY ROAD SUITE 400 SAN DIEGO CA 92121 8582599405
MABVAX THERAPEUTICS HOLDINGS, INC. (Filer) CIK: 0001109196 (see all company filings)

IRS No.: 930987903 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37861 | Film No.: 181196163
SIC: 2834 Pharmaceutical Preparations